Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s00296-014-3133-9
Published Online: 2014-09-17
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Krishnan, Asha
Stobaugh, Derrick J.
Deepak, Parakkal
Text and Data Mining valid from 2014-09-17